LivaNova (LIVN) Net Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 10,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,969.00 |
| Dec 31, 2025 | -880.00 |
| Sep 30, 2025 | -286.00 |
| Jun 30, 2025 | 257.00 |
| Mar 31, 2025 | -8,908.00 |
| Dec 31, 2024 | 1,209.00 |
| Sep 30, 2024 | 1,289.00 |
| Jun 30, 2024 | 473.00 |
| Mar 31, 2024 | -1,702.00 |
| Dec 31, 2023 | 466.00 |
| Sep 30, 2023 | 3,997.00 |
| Jun 30, 2023 | -608.00 |
| Mar 31, 2023 | 155.00 |
| Dec 31, 2020 | -25.00 |
| Dec 31, 2019 | 41.00 |
| Jun 30, 2019 | 162.00 |
| Dec 31, 2018 | 2,848.00 |
| Sep 30, 2018 | -66.00 |
| Jun 30, 2018 | -226.00 |
| Mar 31, 2018 | -95.00 |
| Dec 31, 2017 | -1,941.00 |
| Sep 30, 2017 | 368.00 |
| Jun 30, 2017 | 221.00 |
| Mar 31, 2017 | 1,219.00 |
| Oct 18, 2015 | -6,069.00 |